Aflac Japan expects momentum from its Anshin Palette medical insurance launch to continue through Q3 and Q4 2026, supporting concurrent marketing with Miraito and Tsumitasu.
Aflac expects full-year 2026 Aflac Japan sales to exceed 2025, with direct-mail campaigns back on track and JPY 80 billion still possible.
Aflac has raised its internal Japan reinsurance ceding limit to 30% of FSA reserves, creating capacity for future Aflac Re Bermuda transactions intended to improve capital efficiency.
Aflac U.S. plans to expand broker adoption of network dental during the second half of 2026, using it as an entry point for broader group voluntary-benefits coverage.
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Aflac Incorporated and 4,900+ companies.